Search Results - "Arias, Cesar"

Refine Results
  1. 1

    The rise of the Enterococcus: beyond vancomycin resistance by Arias, Cesar A., Murray, Barbara E.

    Published in Nature reviews. Microbiology (01-04-2012)
    “…Key Points Enterococci are some of the most versatile organisms found to infect hospitalized patients. The epidemiology of enterococcal infections has evolved…”
    Get full text
    Journal Article
  2. 2

    Mechanisms of Antibiotic Resistance by Munita, Jose M, Arias, Cesar A

    Published in Microbiology spectrum (01-04-2016)
    “…Emergence of resistance among the most important bacterial pathogens is recognized as a major public health threat affecting humans worldwide…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge by Arias, Cesar A, Murray, Barbara E

    Published in The New England journal of medicine (29-01-2009)
    “…Drs. Cesar Arias and Barbara Murray write that we have arrived at a point as frightening as the preantibiotic era: for patients infected with…”
    Get full text
    Journal Article
  5. 5

    ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics by Miller, William R., Arias, Cesar A.

    Published in Nature reviews. Microbiology (01-10-2024)
    “…The rise of antibiotic resistance and a dwindling antimicrobial pipeline have been recognized as emerging threats to public health. The ESKAPE pathogens —…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Mechanisms of antibiotic resistance in enterococci by Miller, William R, Munita, Jose M, Arias, Cesar A

    Published in Expert review of anti-infective therapy (01-10-2014)
    “…Multidrug-resistant (MDR) enterococci are important nosocomial pathogens and a growing clinical challenge. These organisms have developed resistance to…”
    Get more information
    Journal Article
  8. 8

    Mechanisms of drug resistance: daptomycin resistance by Tran, Truc T., Munita, Jose M., Arias, Cesar A.

    Published in Annals of the New York Academy of Sciences (01-09-2015)
    “…Daptomycin (DAP) is a cyclic lipopeptide with in vitro activity against a variety of Gram‐positive pathogens, including multidrug‐resistant organisms. Since…”
    Get full text
    Journal Article
  9. 9

    A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis by Beganovic, Maya, Luther, Megan K, Rice, Louis B, Arias, Cesar A, Rybak, Michael J, LaPlante, Kerry L

    Published in Clinical infectious diseases (02-07-2018)
    “…This review highlights available treatment options and their limitations, and provides direction for future investigative efforts to aid in the treatment of…”
    Get full text
    Journal Article
  10. 10

    A New Antibiotic and the Evolution of Resistance by Arias, Cesar A, Murray, Barbara E

    Published in The New England journal of medicine (19-03-2015)
    “…The isolation and cultivation of antibiotic-producing bacteria can yield a rich supply of bacteria that produce new antibiotics to which pathogens are…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci by Miller, William R, Bayer, Arnold S, Arias, Cesar A

    “…Lipopeptides are natural product antibiotics that consist of a peptide core with a lipid tail with a diverse array of target organisms and mechanisms of…”
    Get full text
    Journal Article
  13. 13

    Infectious Diseases Training in the 21st Century: A Glass Half Full or Half Empty? by Arias, Cesar A, Pirofski, Liise-anne

    Published in The Journal of infectious diseases (14-03-2024)
    “…Abstract The percentage of infectious diseases (ID) fellowship positions filled has declined in the last years despite a relatively stable number of…”
    Get full text
    Journal Article
  14. 14

    Resistance in Vancomycin-Resistant Enterococci by Miller, William R., Murray, Barbara E., Rice, Louis B., Arias, Cesar A.

    “…Serious infections owing to vancomycin-resistant enterococci have historically proven to be difficult clinical cases, requiring combination therapy and…”
    Get full text
    Journal Article
  15. 15

    Evaluation of Susceptibility Testing Methods for Aztreonam and Ceftazidime-Avibactam Combination Therapy on Extensively Drug-Resistant Gram-Negative Organisms by Khan, Ayesha, Erickson, Samuel G, Pettaway, Cedric, Arias, Cesar A, Miller, William R, Bhatti, Micah M

    Published in Antimicrobial agents and chemotherapy (18-10-2021)
    “…Carbapenem-resistant (CRE) and Pseudomonas aeruginosa (CR-PA) producing metallo-β-lactamases (MBLs) cause severe nosocomial infections with no defined…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Evolving Resistance Among Gram-positive Pathogens by Munita, Jose M., Bayer, Arnold S., Arias, Cesar A.

    Published in Clinical infectious diseases (15-09-2015)
    “…Antimicrobial therapy is a key component of modern medical practice and a cornerstone for the development of complex clinical interventions in critically ill…”
    Get full text
    Journal Article
  18. 18

    Supervised Machine Learning-Assisted Driving Stress Monitoring MIMO Radar System by Lopez, Maria-Jose, Arias, Cesar Palacios, Romeu, Jordi, Jofre-Roca, Luis

    Published in IEEE sensors journal (01-12-2023)
    “…Factors such as road traffic, challenging ambient temperature conditions, and extended periods of driving have detrimental effects on the physical and mental…”
    Get full text
    Journal Article
  19. 19

    Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content by Mishra, Nagendra N, Bayer, Arnold S, Tran, Truc T, Shamoo, Yousif, Mileykovskaya, Eugenia, Dowhan, William, Guan, Ziqiang, Arias, Cesar A

    Published in PloS one (27-08-2012)
    “…The lipopeptide antibiotic, daptomycin (DAP) interacts with the bacterial cell membrane (CM). Development of DAP resistance during therapy in a clinical strain…”
    Get full text
    Journal Article
  20. 20

    Antimicrobial Agents and Chemotherapy Launches a New Section Focused on Innovative Antimicrobial Stewardship Studies by Tamma, Pranita D, Arias, Cesar A, Shields, Ryan K

    Published in Antimicrobial agents and chemotherapy (15-06-2023)
    “…In response to the global burden of antimicrobial resistance (AMR) and the critical role antimicrobial stewardship plays in optimizing antibiotic use and…”
    Get full text
    Journal Article